AUTL vs XEL · rev $71.9M vs P/E 20, $39.33B cap
Autolus Therapeutics Ltd (AUTL) versus Xcel Energy Inc (XEL) — a side-by-side from cached financials, not a winner call.
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
Xcel Energy Inc (XEL) is a utilities - regulated electric company listed on US.
Latest reported AUTL revenue for 2026-06-30 was $71.9M. Net income was -$110.7M. AUTL currently screens at market cap $614.8M.
XEL does not have a complete income-statement cache yet.
AUTL currently screens at market cap $614.8M. XEL currently screens at market cap $39.33B and trailing P/E 20.1.
Not investment advice. Open the AUTL and XEL stock pages for the full models.
Not investment advice.